Literature DB >> 7987402

Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese.

E A Stephens1, J A Taylor, N Kaplan, C H Yang, L L Hsieh, G W Lucier, D A Bell.   

Abstract

Human cytochrome P4502E1 (CYP2E1) is inducible by ethanol and is involved in metabolism of many known carcinogens including N-nitrosodimethylamine, butadiene, benzene, and carbon tetrachloride. A 50-fold variability in CYP2E1 enzyme activity in humans has been observed but it is unknown whether the basis for this variation is genetic or environmental. Recently, two restriction fragment length polymorphisms (RFLPs) within the CYP2E1 gene have been suggested as genetic markers of risk for cancer. The first was a Rsa I polymorphism in the 5' regulatory region that appeared to alter transcriptional activation of the gene and the second was a Dra I polymorphism located approximately 7000 bp downstream in an intron. Rare alleles at each of these loci have been associated with a reduced risk for lung cancer in Japanese and Swedish populations. We have used a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method to determine the genotype frequency for each of these CYP2E1 RFLPs in 695 individuals of Taiwanese, African-American or European-American background. Genotype and allele frequencies for Taiwanese were significantly different from those of African-Americans and European-Americans at either Rsa I or Dra I sites (p < 0.0001). Allele frequencies for African-Americans and European-Americans were significantly different at the Rsa I site (p = 0.03). The rare alleles (c2 and C) occurred at frequencies of 0.28 and 0.24 in Taiwanese, 0.01 and 0.08 in African-Americans, and 0.04 and 0.11 in European-Americans. In addition, we describe three haplotypes common to all three population samples and a fourth haplotype that was only detected in the Taiwanese population sample. This fourth haplotype may have been caused by a recombination event between these markers.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7987402     DOI: 10.1097/00008571-199408000-00002

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  30 in total

1.  Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, including meta-analysis.

Authors:  N A Wong; F Rae; K J Simpson; G D Murray; D J Harrison
Journal:  Mol Pathol       Date:  2000-04

2.  Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.

Authors:  S Liu; J Y Park; S P Schantz; J C Stern; P Lazarus
Journal:  Oral Oncol       Date:  2001-07       Impact factor: 5.337

3.  Racializing drug design: implications of pharmacogenomics for health disparities.

Authors:  Sandra Soo-Jin Lee
Journal:  Am J Public Health       Date:  2005-10-27       Impact factor: 9.308

4.  Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer.

Authors:  Chikako Kiyohara; Taro Shirakawa; Julian M Hopkin
Journal:  Environ Health Prev Med       Date:  2002-05       Impact factor: 3.674

5.  APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population.

Authors:  Chikako Kiyohara; Yoshihiro Miyake; Midori Koyanagi; Takahiro Fujimoto; Senji Shirasawa; Keiko Tanaka; Wakaba Fukushima; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Takami Miki; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

6.  Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.

Authors:  N Ben Fredj; R Gam; E Kerkni; A Chaabane; Z Chadly; N Boughattas; K Aouam
Journal:  Pharmacogenomics J       Date:  2016-04-19       Impact factor: 3.550

7.  Genetic Determinants of 1,3-Butadiene Metabolism and Detoxification in Three Populations of Smokers with Different Risks of Lung Cancer.

Authors:  Emily J Boldry; Yesha M Patel; Srikanth Kotapati; Amanda Esades; Sungshim L Park; Maarit Tiirikainen; Daniel O Stram; Loïc Le Marchand; Natalia Tretyakova
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-03-14       Impact factor: 4.254

8.  Cytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia.

Authors:  Xiu-Lan Su; Ba Bin; Hong-Wei Cui; Mei-Rong Ran
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

9.  Phenol sulphotransferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations.

Authors:  M W Coughtrie; R A Gilissen; B Shek; R C Strange; A A Fryer; P W Jones; D E Bamber
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

10.  Newborn screening archives as a specimen source for epidemiologic studies: feasibility and potential for bias.

Authors:  Susan Searles Nielsen; Beth A Mueller; Anneclaire J De Roos; Harvey Checkoway
Journal:  Ann Epidemiol       Date:  2008-01       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.